期刊文献+

类风湿关节炎合并间质性肺病患者血清表面活性蛋白A和D水平及临床意义 被引量:9

Detection of serum surfactant protein A and D levels in serum of patients with interstitial lung disease associated with rheumatoid arthritis
原文传递
导出
摘要 目的探讨类风湿关节炎(RA)合并间质性肺病(ILD)患者的血清表面活性蛋白A(SP-A)和D(SP-D)水平及临床意义。方法采用双抗体夹心酶联免疫吸附试验(ELISA)法检测SP-A和SP-D,并比较单纯RA组、RA-ILD组、对照组血清样本SP-A和SP-D水平的差异,分析其与RA合并ILD的相关性。计算3组血清SP-A和SP-D阳性检出率。分析SP—A和SP-D与年龄、红细胞沉降率(ESR)、C反应蛋白(CRP)、类风湿因子(RF)、抗环瓜氨酸肽(CCP)抗体、抗核抗体、抗核周因子(APF)和抗角蛋白抗体(AKA)之间的相关性。多组间均数的比较采用方差分析,数据间的相关性分析采用Spearman等级相关。结果①RA—ILD组、单纯RA组、对照组的血清SP-A水平分别为(51.2±9.2)、(25.9±2.6)、(15.4±0.3)μg/L,SP—D水平分别为(42.5±8.1)、(20.8±1.5)、(16.6±0.8)μg/L。RA-ILD组患者血清SP-A和SP-D水平高于单纯RA组以及对照组(P〈0.05)。单纯RA组患者血清SP-A和SP-D水平和健康对照组比较差异无统计学意义(P〉0.05)。②RA-ILD组血清SP—A和SP-D的阳性率明显高于单纯RA组(χ^2=5.21,P=0.02;χ^2=4.79,P=0.01)和健康对照组(χ^2=4.96,P=0.03;χ^2=4.75,P=0.02),RA—ILD组血清SP-D的阳性检出率大于血清SP—A(χ^2=4.95,P=0.04)。③RA—ILD患者血清SP-A、SP—D水平与年龄、CRP呈正相关(r=0.687,P=-0.001;r=-0.571,P=-0.009)。④RA—ILD患者血清SP—D水平与RF、抗CCP抗体和AKA呈正相关,而血清SP—A、SP-D水平与抗核抗体、APF、ESR无相关性。结论①SP—A和SP—D可作为RA合并ILD的血清学标志;②SP-A和SP-D在早期诊断RA合并ILD方面有一定价值,SP-D更有效地提示RA合并ILD存在,判断肺损伤程度,预测疾病转归情况。 Objective To measure serum surfactant protein (SP) A and D levels in patients with inter- stitial lung disease associated with rheumatoid arthritis (RA). Methods Serum SP-A and SP-D levels of RA, RA-ILD patients and healthy controls were assessed using a sensitive enzyme-linKed immunosorbent assay (ELISA). The relationship between SP-A and SP-D and RA-ILD was analyzed. The serum SP-A and SP-D positive rate was calculated for the three groups. The correlation between SP-A and SP-D with RF, anti-CCP, antinuclear antibody, antikeratin antibody, anti-perinuclear factor, C-reactive protein, erythrocyte sediment- ation rate, were analyzed. Mean value of groups were compared with variance analysis, Spearmarn rank correlation test was used for correlation analysis. Results The levels of serum SP-A in RA-ILD patients and RA patients as well as in healthy controls were [ (51.2±9.2), (25.9±2.6), (15.4±0.3) μg/L ] respectively. The level of serum SP-D of the three groups was [ (42.5±8.1), (20.8±1.5), (16.6±0.8) μg/L] respectively. The levels of serum SP-A and SP-D in patients with RA complicated with ILD were higher than those simple RA patients and healthy controls (P〈0.05). The levels of serum SP-A and SP-D in patients with RA were not significaritly higher than those in healthy controls (P〉0.05). The positive rate of serum SP-A and SP-D in RA-ILD patients were significantly higher than those in simple RA patients and healthy controls. The positive rate of serum SP-D of RA-ILD patients was higher than that of SP-A. The levels of serum SP-A and SP-D in patients with RA complicated with ILD were correlated positively with age, C-reactive protein. The level of serum SP-D was correlated positively with RF, anti-CCP, antikeratin antibody. There was no correlation between the level of serum SP-A and SP-D with RA-ILD and antinuclear antibody,antiperinuclear factor, erythrocyte sedimentation rate. Conclusion The levels of serum SP-A and SP-D are correlated with RA-ILD and may be useful markers for ILD in patients with RA. These two paramenters may be helpful to early diagnosis of RA-ILD. The Serum SP-D levels are more sensitive in predicting the development of RA-ILD than other parameters and can help in assessing the severity of lung damage.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2012年第7期463-467,共5页 Chinese Journal of Rheumatology
基金 太原市科技计划专项资助项目(100341)
关键词 关节炎 类风湿 肺疾病 间质性 肺表面活性物质相关蛋白质类 诊断 Arthritis, rheumatoid Lung disease, interstitial Pulmonary surfactant-associated proteins Diagnosis
  • 相关文献

参考文献14

  • 1Amett FC,Edworth SM,Bloch DA. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis[J].Arthritis and Rheumatism,1988.315-324.
  • 2American Thoracic Society. Idiopathic pulmonary fibrosis:diagnosis and treatment.International consensus statement.American Thoracic Society (ATS),and the European Respiratory Society (ERS)[J].American Journal of Respiratory and Critical Care Medicine,2000.646-664.
  • 3刘晓立,吕长俊,王晓芝.血清肺表面活性蛋白A、D在间质性肺疾病中的价值[J].国际呼吸杂志,2008,28(15):944-946. 被引量:5
  • 4Villeneuve E,Nam J,Emery P. 2010 ACR-EULAR classification criteriafor rheumatoid arthritis[J].Rev Bras Rheumatol,2010.481-483.
  • 5Trapnell BC,Whitstt JA. GM-CSF regulates pulmonary surfac tant.Homeostasis and alveolar macrophage-mediated:innate host defense[J].Annual Review of Physiology,2002.775-802.
  • 6Halliday HL. Surfactants:past,present and future[J].Journal of Perinatology,2008.47-56.
  • 7Bilgici A,Ulusoy H,Kuru O. Pulmonary involvement in rheumatoid arthritis[J].Rheumatology International,2005.429-435.
  • 8Alexiou I,Germenis A,Koutroumpas A. Acyclic citrullinated peptide-2(CCP2)autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis[J].Clinical Rheumatology,2008.511-513.
  • 9Sakaida H. IgG rheumatoid factor in rheumatoid arthritis with interstitial lung disease[J].Ryumachi,1995.671-677.
  • 10Janssen R,Sato H,Grutters JC. Study of Clara cell 16,KL-6,and suffactant protein-D in serum as disease markers in pulmonary sarcoidosis[J].Chest,2003.2119-2125.

二级参考文献16

  • 1Takahashi H, Sano H, Chiba H, et al. Pulmonary surfactant proteins A and D: innate immune functions and biomarkers for lung diseases. Curr Pharm Des, 2006,12 : 589-598.
  • 2Lvnch JP 3rd, Saggar R, Weigt SS, et al. Usual Interstitial Pneumonia. Semin Respir Crit Care Med,2006,27 : 634-651.
  • 3Tzouvelekis A, Kouliatsis G, Anevlavis S, et al. Serum biomarkers in interstitial lung diseases. Respir Res, 2005,6:78.
  • 4Khamri W, Moran AP, Worku ML, et al. Variations in Helicobacter pylori lipopolysaccharide to evade the innate immune component surfactant protein D. Infect Immun, 2005, 73:7677-7686.
  • 5Madsen J, Kliem A, Tornoe I, et al. Localisation of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol, 2000,164 : 5866-5870.
  • 6Ni M, Evans DJ, Hawgood S, et al. Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa. Infect Immun, 2005, 73:2147-2156.
  • 7Pastva AM,Wright JR, Williams KL. Immunomodulatory roles of surfactant proteins A and D:implications in lung disease. Proc Am Thorac Soc,2007,4: 252-257.
  • 8Ikegami M, Jobe AH, Whitsett J, et al. Tolerance of SP-Adeficient mice to hyperoxia or exercise. J Appl Physiol, 2000,89 : 644-648.
  • 9Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol,2005,5 : 58-68.
  • 10Nogee LM. Genetic mechanisms of surfactant deficiency. Biol Neonate,2004,85 : 314-318.

共引文献4

同被引文献72

引证文献9

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部